AR007493A1 - Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica - Google Patents

Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica

Info

Publication number
AR007493A1
AR007493A1 ARP970101333A ARP970101333A AR007493A1 AR 007493 A1 AR007493 A1 AR 007493A1 AR P970101333 A ARP970101333 A AR P970101333A AR P970101333 A ARP970101333 A AR P970101333A AR 007493 A1 AR007493 A1 AR 007493A1
Authority
AR
Argentina
Prior art keywords
spray dried
genetic therapy
dried microparticles
therapeutic vehicles
microparticles
Prior art date
Application number
ARP970101333A
Other languages
English (en)
Spanish (es)
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of AR007493A1 publication Critical patent/AR007493A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP970101333A 1996-04-03 1997-04-03 Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica AR007493A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
GB9601379 1996-06-07

Publications (1)

Publication Number Publication Date
AR007493A1 true AR007493A1 (es) 1999-11-10

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101333A AR007493A1 (es) 1996-04-03 1997-04-03 Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica

Country Status (14)

Country Link
EP (1) EP0936902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000507568A (cg-RX-API-DMAC7.html)
AR (1) AR007493A1 (cg-RX-API-DMAC7.html)
AT (1) ATE243027T1 (cg-RX-API-DMAC7.html)
AU (1) AU715512B2 (cg-RX-API-DMAC7.html)
CA (1) CA2250478A1 (cg-RX-API-DMAC7.html)
DE (1) DE69722952T2 (cg-RX-API-DMAC7.html)
DK (1) DK0936902T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201283T3 (cg-RX-API-DMAC7.html)
GB (1) GB9607035D0 (cg-RX-API-DMAC7.html)
NO (1) NO984462L (cg-RX-API-DMAC7.html)
PT (1) PT936902E (cg-RX-API-DMAC7.html)
WO (1) WO1997036578A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA972837B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
DE69608122T3 (de) 1995-11-09 2011-06-16 Microbiological Research Authority Camr, Salisbury Mikroverkapselte dna zur impfung und gentherapie
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
WO2002015880A2 (en) * 2000-08-25 2002-02-28 Merck Patent Gmbh Powdered mannitol and mannitol-containing compositions
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP1765294B1 (en) 2004-05-12 2008-09-24 Baxter International Inc. Nucleic acid microspheres, production and delivery thereof
CA2566199C (en) 2004-05-12 2013-10-22 Baxter International Inc. Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
CN101500616A (zh) 2006-08-04 2009-08-05 巴克斯特国际公司 预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
CN101686939B (zh) 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
JP7422977B2 (ja) * 2018-07-23 2024-01-29 トランスレイト バイオ， インコーポレイテッド メッセンジャーｒｎａ用乾燥粉末製剤
AU2020206984A1 (en) * 2019-01-09 2021-07-15 Ziccum Ab Stabilized non-enveloped virus compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
KR100208979B1 (ko) * 1992-06-12 1999-07-15 야스이 쇼사꾸 기도내 투여용 제제
AU6637394A (en) * 1993-04-19 1994-11-08 Medisorb Technologies International L.P. Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
MX9605717A (es) * 1994-05-18 1998-05-31 Inhale Therapeutic Syst Metodos y composiciones para la formulacion de polvo seco de interferones.
NZ292980A (en) * 1994-09-29 1999-02-25 Andaris Ltd Smooth, spherical water-soluble microparticles as therapeutic or diagnostic vehicles
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
EP0840623B1 (en) * 1995-07-21 2007-07-18 Brown University Research Foundation Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles

Also Published As

Publication number Publication date
CA2250478A1 (en) 1997-10-09
GB9607035D0 (en) 1996-06-05
DE69722952D1 (de) 2003-07-24
DK0936902T3 (da) 2003-10-06
PT936902E (pt) 2003-11-28
WO1997036578A1 (en) 1997-10-09
ATE243027T1 (de) 2003-07-15
DE69722952T2 (de) 2003-12-11
EP0936902A1 (en) 1999-08-25
EP0936902B1 (en) 2003-06-18
ZA972837B (en) 1998-04-03
AU715512B2 (en) 2000-02-03
AU2302097A (en) 1997-10-22
NO984462D0 (no) 1998-09-25
JP2000507568A (ja) 2000-06-20
NO984462L (no) 1998-09-25
ES2201283T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
AR007493A1 (es) Microparticulas secadas por rociado como vehiculos terapeuticos para uso en terapia genetica
TR200100144T2 (tr) Farmasötik aerosol formülasyonu
PT904056E (pt) Processo e dispositivo para inalacao de medicamentos particulados
GB2231495A (en) Enhanced uptake drug delivery system
ES2195408T3 (es) Microparticulas perforadas y procedimientos de uso.
DE69533128D1 (de) Pharmazeutische akzeptabel dnase zusammensetzung
EE9700176A (et) Kuivpulbriinhalaatorites kasutatav pulber, selle valmistamismeetod, selles kasutatavad osakesed ja meetod nende valmistamiseks ning pulbri lisandi kasutamine
DE69533744D1 (de) Yttria partikelförmiges gut
BR9510210A (pt) Dispositivo de inalação e processo para dispersão de uma substância farmaceuticamente ativa em uma câmara de dispersão e para administração de uma dose de uma substância farmaceuticamente ativa em pó
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
ES2116353T3 (es) Polvos para inhalacion y procedimiento para su fabricacion.
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
NO934315D0 (no) Farmas!ytisk b{rer
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
PT1010688E (pt) 2-fenil-1-(3,4-di-hidroxi-5-nitrofenil)-1-etanonas substituidas seu uso no tratamento de algumas perturbacoes do sistema nervoso central e periferico e formulacoes do sistema nervoso central e periferico e formulacoes farmaceuticas que as contem
BR9814924A (pt) Microgrânulos de omeprazol, processo de preparação dos mesmos, e, preparações farmacêuticas
DK1107737T3 (da) Mikropartikler til anvendelse ved nålelös injektion
NL300330I1 (nl) Preparaat voor het afgeven van peptiden
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
ES2071995T3 (es) Composicion para la activacion de macrofagia.
PT1007717E (pt) Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem

Legal Events

Date Code Title Description
FA Abandonment or withdrawal